RASBURNAT 1.5MG

Rasburnat 1.5Mg Inj is a recombinant form of the enzyme urate oxidase, utilized to lower uric acid levels in patients with leukaemia, lymphoma, and solid tumor malignancies undergoing anti-cancer treatment. Leukaemia, also known as blood cancer, affects blood cells or blood-forming tissues. Lymphoma is a type of cancer that targets the lymphatic system.

Rasburnat 1.5Mg Inj contains Rasburicase, which is classified as a recombinant urate-oxidase enzyme. It functions by metabolizing the recombinant urate oxidase enzyme, thereby assisting in the reduction of uric acid levels.

Rasburnat 1.5Mg Inj may lead to various side effects, including vomiting, nausea, fever, constipation, diarrhoea, oedema, headache, abdominal pain, anxiety, and reactions at the injection site. Most of these side effects are not serious and typically resolve on their own over time. Administration of Rasburnat 1.5Mg Inj should be performed by a qualified healthcare professional; self-administration is not advised.

If you have an allergy to Rasburnat 1.5Mg Inj, please notify your doctor and refrain from using it. It is important to provide your doctor with your full medical and medication history prior to beginning treatment with Rasburnat 1.5Mg Inj. This medication is contraindicated for pregnant and breastfeeding women due to the potential for serious harm to the fetus. Therefore, inform your doctor if you are pregnant or planning to conceive. Additionally, notify your doctor if you have a history of kidney or liver disease.